Published in JAMA on January 01, 1997
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest (1997) 2.94
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun (2000) 2.19
Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol (2005) 1.90
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci U S A (1998) 1.85
The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe (2008) 1.68
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol (2006) 1.65
Retracted Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun (2001) 1.61
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A (2011) 1.39
Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun (1999) 1.36
Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis (2011) 1.32
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein. J Clin Microbiol (1997) 1.28
Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol (2009) 1.27
A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion. Infect Immun (1998) 1.19
Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect Immun (2000) 1.18
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol (2012) 1.08
Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis (2003) 1.06
Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun (2006) 1.05
Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus. J Bacteriol (2006) 1.03
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. Proc Natl Acad Sci U S A (2000) 1.02
Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect Immun (2001) 1.01
Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerg Microbes Infect (2012) 1.01
Group A Streptococcal Sepsis. Curr Infect Dis Rep (2003) 1.00
Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999. J Clin Microbiol (2004) 1.00
The pathogenicity of the Streptococcus genus. Eur J Clin Microbiol Infect Dis (2013) 0.99
Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J Innate Immun (2010) 0.94
Invasive group A streptococcal infections. Paediatr Child Health (1999) 0.94
Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils. Infect Immun (2005) 0.88
Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains. Infect Immun (2013) 0.88
Generation of metabolically diverse strains of Streptococcus pyogenes during survival in stationary phase. J Bacteriol (2009) 0.84
Therapeutic Approaches to Streptococcal Toxic Shock Syndrome. Curr Infect Dis Rep (1999) 0.83
Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells. MBio (2012) 0.83
Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey. J Clin Microbiol (2003) 0.82
Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities. Emerg Infect Dis (2003) 0.80
Long-term survival of salivary streptococci on dental devices made of ethylene vinyl acetate. Int J Oral Sci (2012) 0.79
Contemporary Pharyngeal and Invasive emm1 and Invasive emm12 Group A Streptococcus Isolates Exhibit Similar In Vivo Selection for CovRS Mutants in Mice. PLoS One (2016) 0.77
Unique Footprint in the scl1.3 Locus Affects Adhesion and Biofilm Formation of the Invasive M3-Type Group A Streptococcus. Front Cell Infect Microbiol (2016) 0.76
Management of pharyngeal carriers of group A streptococcal organisms. JAMA (1997) 0.75
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol (1986) 24.31
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (1983) 19.44
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A (1997) 15.25
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol (1999) 11.63
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis (1998) 11.56
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA (1996) 9.45
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol (1994) 6.91
Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis (1991) 6.69
Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect Immun (1990) 6.42
Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A (2001) 6.22
Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med (1999) 6.20
Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun (1986) 5.92
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Population genetics of pathogenic bacteria. Microb Pathog (1987) 5.59
Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 5.46
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol (1991) 5.45
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA (1999) 5.25
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A (2001) 5.21
Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis (2001) 5.07
Genetic characterization of clones of the bacterium Listeria monocytogenes causing epidemic disease. Proc Natl Acad Sci U S A (1989) 5.00
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1985) 4.48
Toward a population genetic analysis of Salmonella: genetic diversity and relationships among strains of serotypes S. choleraesuis, S. derby, S. dublin, S. enteritidis, S. heidelberg, S. infantis, S. newport, and S. typhimurium. Proc Natl Acad Sci U S A (1988) 4.43
Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med (1987) 4.38
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol (1999) 4.15
A national outbreak of Salmonella enteritidis infections from ice cream. The Investigation Team. N Engl J Med (1996) 4.14
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis (1994) 3.97
Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis (1998) 3.96
Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis (1993) 3.94
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
Infectious disease surveillance: a crumbling foundation. Science (1994) 3.89
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis (1985) 3.81
Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science (1998) 3.81
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis. J Clin Microbiol (1996) 3.70
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol (1992) 3.56
Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis (1992) 3.52
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet (1992) 3.46
Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother (1997) 3.46
Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping. J Clin Microbiol (2000) 3.38
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 3.33
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med (1997) 3.28
Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system. J Clin Microbiol (2000) 3.26
Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med (1984) 3.26
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. Tuber Lung Dis (1998) 3.15
Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol Microbiol (1994) 3.14
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med (1990) 3.05
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother (1997) 3.05
Penicillin-resistant Streptococcus pneumoniae strains recovered in Houston: identification and molecular characterization of multiple clones. J Infect Dis (1993) 3.03
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis (1983) 3.00
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog (1993) 2.99
An outbreak of foodborne giardiasis. N Engl J Med (1981) 2.98
Aeromonas veronii, a new ornithine decarboxylase-positive species that may cause diarrhea. J Clin Microbiol (1987) 2.97
Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg Infect Dis (1999) 2.96
Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest (1997) 2.94
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol (1980) 2.93
Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A (1993) 2.92
Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol (1992) 2.90
Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc Natl Acad Sci U S A (2001) 2.90
Cyclosporiasis and raspberries--lessons for the future. N Engl J Med (1997) 2.86
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun (1989) 2.77
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob Agents Chemother (1996) 2.75
Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother (1997) 2.70
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis (1991) 2.65
Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med (1997) 2.63
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem (1986) 2.63
Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc (1997) 2.62
Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.62
Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med (1992) 2.60
Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect Immun (1977) 2.59